Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Juan P. Nogueira"'
Autor:
Walter Masson, Leandro Barbagelata, Milagros Fleitas, Nicole Herzkovich, Eliana Kerschner, Emiliano Rossi, Daniel Siniawski, María V. Ami, Juan P. Nogueira
Publikováno v:
Archives of Endocrinology and Metabolism (2023)
ABSTRACT Objective: Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive metabolic disorder caused by mutations related to chylomicron metabolism. The objective of this study is to show the development and results of a screening prog
Externí odkaz:
https://doaj.org/article/eb8cccf5866d4dd092c22de5c964697d
Autor:
Walter Masson, Martin Lobo, Daniel Siniawski, Graciela Molinero, Gerardo Masson, Melina Huerín, Juan Patricio Nogueira
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Several studies have investigated the association between non-statin lipid-lowering therapy and regression of atherosclerosis. However, these studies were mostly small and their results were not always robust. The objectives were:
Externí odkaz:
https://doaj.org/article/eebf65eecbfe45d689374e0c9b88accf
Autor:
Juan Patricio Nogueira
Publikováno v:
Revista Científica Ciencias de la Salud, Pp 57-66 (2019)
La resistencia a la insulina, la diabetes tipo 2 y la obesidad, se caracterizan por un aumento en las lipoproteínas ricas en triglicéridos debido a la reducción del catabolismo de TRL de la circulación y al aumento de la producción hepática (ap
Externí odkaz:
https://doaj.org/article/d7bf76e5c3fe4155b05e9c0f39e94eee
Autor:
Walter Masson, Leandro Barbagelata, Pablo Oberti, Mariano Falconi, Augusto Lavalle-Cobo, Pablo Corral, Juan P. Nogueira
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 33:925-933
Autor:
Juan Facundo Nogueira, Guido Simonelli, Vanina Giovini, María Florencia Angellotti, Eduardo Borsini, Glenda Ernst, Carlos Nigro
Publikováno v:
Sleep Science, Vol 11, Iss 3, Pp 174-182 (2018)
Introduction: The most effective treatment for moderate to severe obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP) but adherence may be a limiting factor. Most compliance studies often only include patients under CPAP tre
Externí odkaz:
https://doaj.org/article/2f167e73be074110bbf1f2b2eec79694
Publikováno v:
Cells, Vol 10, Iss 8, p 2150 (2021)
(1) Sodium–glucose cotransporter-2 inhibitors (SGLT2-i) reduce adipose tissue and cardiovascular events in patients with type 2 diabetes (T2D). Accumulation of epicardial adipose tissue (EAT) is associated with increased cardio-metabolic risks and
Externí odkaz:
https://doaj.org/article/a9c4b1117a414792b04ec0333781e82e
Autor:
Walter Masson, Pablo Corral, Leandro Barbagelata, Augusto Lavalle-Cobo, Juan P Nogueira, Daniel Siniawski, Kausik K Ray
Publikováno v:
Journal of Clinical Lipidology. 16:562-573
Lipid-lowering medication is effective in reducing the risk of cardiovascular disease in several clinical scenarios. However, the evidence in patients with familial hypercholesterolemia (FH) and severe primary hypercholesterolemia is less robust.The
Autor:
Walter Masson, Leandro Barbagelata, Martín Lobo, Gabriela Berg, Augusto Lavalle-Cobo, Juan P. Nogueira
Publikováno v:
Archives of Gynecology and Obstetrics.
Autor:
Gustavo Cárdenas, Juan J. Nogueira
Publikováno v:
Molecules, Vol 25, Iss 24, p 5927 (2020)
The design of more efficient photosensitizers is a matter of great importance in the field of cancer treatment by means of photodynamic therapy. One of the main processes involved in the activation of apoptosis in cancer cells is the oxidative stress
Externí odkaz:
https://doaj.org/article/1ff1a32cbb614884999931075eec4e1c
Autor:
Walter Masson, Leandro Barbagelata, Pablo Corral, Juan P. Nogueira, Augusto Lavalle-Cobo, Alejandra Belardo
Publikováno v:
Current Problems in Cardiology. 48:101589
Elevated lipoprotein(a) [Lp(a)] levels are independently associated with atherosclerotic cardiovascular disease, although this association is less explored in postmenopausal women. The main objective of this systematic review was to analyze the assoc